Latest data from October 8, 2021
Number of Health Center respondents = 15 (94% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 4,303 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 82.03% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 1,190 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 24.05% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 13.64% | 63.70% |
| White, Hispanic/Latino Patients | 48.20% | 15.55% |
| Black/African American, Non-Hispanic/Latino Patients | 0.86% | 0.34% |
| Black/African American, Hispanic/Latino Patients | 0.19% | 0.17% |
| Asian Patients3 | 0.58% | 0.00% |
| American Indian/Alaska Native Patients3 | 6.09% | 0.59% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.02% | 0.00% |
| Patients with More than one race3 | 0.88% | 0.76% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 5.44% | 2.77% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.67% | 2.18% |
| Unreported/Refused to Report Race and Ethnicity | 23.43% | 13.95% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 873 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 82.81% |
| COVID-19 Immunization Series Completed | 1,221 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 85.52% |
| COVID-19 Immunization Series Additional | 1,231 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 64.10% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 13.75% | 12.37% | 29.16% |
| White, Hispanic/Latino Patients | 53.49% | 60.11% | 42.00% |
| Black/African American, Non-Hispanic/Latino Patients | 1.15% | 2.29% | 0.41% |
| Black/African American, Hispanic/Latino Patients | 0.46% | 0.41% | 0.00% |
| Asian Patients3 | 0.57% | 0.49% | 0.49% |
| American Indian/Alaska Native Patients3 | 6.19% | 4.83% | 0.49% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.46% | 0.25% | 0.08% |
| Patients with More than one race3 | 0.80% | 0.90% | 1.30% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.09% | 3.77% | 7.31% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.26% | 0.49% | 2.84% |
| Unreported/Refused to Report Race and Ethnicity | 18.79% | 14.09% | 15.92% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 20.00% |
| 1 to 24 Hours | 40.00% |
| More Than 24 Hours | 40.00% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 6.67% |
| Staffing to administer the vaccine | 13.33% |
| Vaccine confidence | 40.00% |
| Vaccine storage capacity | 6.67% |
| Vaccine supply | 0.00% |
| Other | 0.00% |
| None | 46.67% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 13.33% |
| Average Percent of Health Center Visits Conducted Virtually | 26.00% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 26.67% |
| Number of Mobile Van Sites | 13 |
| Number of Pop-up Clinics | 10 |
| Number of School-Based Vaccination Sites | 4 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 0.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 60.00% |
| None | 40.00% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 20.00% |
| Patient awareness/education | 6.67% |
| Staffing capacity | 20.00% |
| Therapy administration/onsite logistics | 6.67% |
| Other | 6.67% |
| None | 60.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
